Hormonal Mechanisms in Thrombosis

1A. Squizzato, V. E. A. Gerdes, W. Ageno & H. R. Büller. The coagulation system in endocrine disorders: A narrative review. Internal and Emergency Medicine, 2007;2,76–83.Search in Google Scholar

2Massimo Franchini, Giuseppe Lippi, Franco Manzato, Pier Paolo Vescovi, Giovanni Targher. Hemostatic abnormalities in endocrine and metabolic disorders. Eur J Endocrinol. 2010;162(3):439-51.Search in Google Scholar

3Stuijver, DJ, van Zaane, B, Romualdi, E. The effect of hyperthyroidism on procoagulant, anticoagulant and fibrinolytic factors: a systematic review and meta-analysis. Thromb Haemost. 2012;108(6):1077–1088.Search in Google Scholar

4Hulbert AJ. Thyroid hormones and their effects: a new perspective. Biol Rev Camb Philos Soc. 2000;75(4):519–631.Search in Google Scholar

5Vescovi PP, Favaloro EJ, Lippi G, Garofano M, Montagnana M, Manzato F, et al. The spectrum of coagulation abnormalities in thyroid disorders. Semin Thromb Hemost. 2011;37(1):7–10.Search in Google Scholar

6Erem C. Coagulation and fibrinolysis in thyroid dysfunction. Endocrine. 2009;36(1):110–8.Search in Google Scholar

7Franchini M. Hemostasis and thyroid diseases revisited. J Endocrinol Invest. 2004;27(9):886–92.Search in Google Scholar

8Massimo Franchini, Pier Paolo Vescovi, Franco Manzato, Emmanuel J. Favaloro. Hormones, Endocrine Disorders, and Hemostasis. Semin Thromb Hemost 2011; 37(1): 003-006.Search in Google Scholar

9Squizzato A, Romualdi E, Piantanida E et al. Subclinical hypothyroidism and deep venous thrombosis. A pilot cross-sectional study. Thromb Haemost. 2007;97(5): 803-806.Search in Google Scholar

10Stuijver DJ, Piantanida E, van Zaane B, et al. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study. Haemophilia. 2014;20(3):326–332.Search in Google Scholar

11Viswanathan G, Balasubramaniam K, Hardy R, et al. Blood thrombogenicity is independently associated with serum TSH levels in post-non-ST elevation acute coronary syndrome. J Clin Endocrinol Metab. 2014;99(6): E1050–E1054.Search in Google Scholar

12Kovarova M, Koller T, Stvrtinova V, et al. Thyroid-stimulating hormone concentration as an independent risk factor of venous thromboembolism regardless of thyroid function. Endokrynol Pol. 2015;66(6):474–479.Search in Google Scholar

13Angelini, D, Khorana, AA. Risk assessment scores for cancer-associated venous thromboembolic disease. Semin Thromb Hemost. 2017;43(5):469–478.Search in Google Scholar

14Charalel, RA, Vedantham, S. Deep vein thrombosis interventions in cancer patients. Semin Intervent Radiol. 2017;34(1):50–53.Search in Google Scholar

15Donnellan, E, Khorana, AA. Cancer and venous thromboembolic disease: a review. Oncologist. 2017;22(2):199–207.Search in Google Scholar

16Streiff, MB. Thrombosis in the setting of cancer. Hematology Am Soc Hematol Educ Program. 2016;2016(1):196–205.Search in Google Scholar

17Meikle CK, Kelly CA, Garg P, et al. Cancer and thrombosis: the platelet perspective. Front Cell Dev Biol. 2016;4:147.Search in Google Scholar

18Marcello De Cicco. The prothrombotic state in cancer: pathogenic mechanisms. Critical Reviews in Oncology/Hematology. Volume 50, Issue 3, June 2004, Pages 187-196Search in Google Scholar

19M.Y. Abou-Ismail, D. Citla Sridhar, L. Nayak. Estrogen and thrombosis: a bench to bedside review. Thromb. Res., 192 (2020), pp. 40-51.Search in Google Scholar

20C. Bushnell, L.D. McCullough, I.A. Awad, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, 45 (5) (2014), pp. 1545-1588.Search in Google Scholar

21C.D. Bushnell, S. Chaturvedi, K.R. Gage, et al. Sex differences in stroke: challenges and opportunities. J. Cereb. Blood Flow Metab., 38 (12) (2018), pp. 2179-2191.Search in Google Scholar

22Stuijver DJ, Romualdi E, van Zaane B, Bax L, Büller HR, Gerdes VEA, Squizzato A. Under-reporting of venous and arterial thrombotic events in randomized clinical trials: a meta-analysis. Intern Emerg Med 2015;10:219-246.Search in Google Scholar

23Shahid M.Nimjee, Asad S.Akhter, Amanda Zakeri, Paco S.Herson. Sex differences in thrombosis as it affects acute ischemic stroke. Neurobiology of Disease, Volume 165, April 2022, 10564.Search in Google Scholar

24North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause 2012; 19:257-271.Search in Google Scholar

25Curb JD, Prentice RL, Bray PF, et al. Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch Intern Med 2006; 166:772-780.Search in Google Scholar

26World Health Organization. Cardiovascular Disease and Steroid Hormone Contraception. Report of a WHO Scientific group. WHO Technical Report Series 877. Geneva: World Health Organization, 1998.Search in Google Scholar

27Canonico M, Oger E, Plu-Bureau G, et al; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007; 115:840–845Search in Google Scholar

28Lemaitre RN, Heckbert SR, Psaty BM, Smith NL, Kaplan RC, Longstreth WT Jr. Hormone replacement therapy and associated risk of stroke in postmenopausal women. Arch Intern Med 2002; 162: 1954-60Search in Google Scholar

29Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002; 288: 980-7.Search in Google Scholar

30Million Women Study Collaborators. Patterns of use of hormone replacement therapy in one million women in Britain, 1996–2000. BJOG 2002; 109: 1319-30.Search in Google Scholar

31Brown NJ, Vaughan DE. Prothrombotic effects of angiotensin. Adv Intern Med. 2000; 45: 419-429.Search in Google Scholar

32Rumbaut RE, Slaff DW, Burns AR. Microvascular thrombosis models in venules and arterioles in vivo. Microcirculation. 2005; 12: 259-274.Search in Google Scholar

33Remkova A, Remko M. The role of renin-angiotensin system in prothrombotic state in essential hypertension. Physiol Res. 2010; 59: 13-23.Search in Google Scholar

34Mogielnicki A, Chabielska E, Pawlak R, Szemraj J, Buczko W. Angiotensin II enhances thrombosis development in renovascular hypertensive rats. Thromb Haemost. 2005; 93: 1069-1076.Search in Google Scholar

35Stankiewicz A, Gromotowicz A, Szemraj J, Wojewódzka-Źelezniakowicz M, Skrzypkowski P, Chabielska E. Acute aldosterone infusion enhances thrombosis development in normotensive rats. Thromb Haemost 2007; 98: 697-699Search in Google Scholar

36Elbers LPB, Sjouke B, Zannad F, Cicoira M, Vizzardi E, Václavík J, Gerdes VEA, Squizzato A. Effects of mineralocorticoid receptor antagonists on the risk of thrombosis, bleeding and mortality: A systematic review and meta-analysis of randomized controlled trials. Thromb Res 2016; 144:32-39.Search in Google Scholar

37Sechi LA, Novello M, Colussi G, Di Fabio A, Chiuch A, Nadalini E, Casanova-Borca A, Uzzau A, Catena C. Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage. Am J Hypertens 2008; 21:1347–1353Search in Google Scholar